To compare the efficacy and safety of recombinant human interferon -2 b ( INF-2b ) monotherapy and combined therapy with entecavir ( ETV ) plus adefovir dipivoxil ( ADV ) in chronic hepatitis B patients with poor response to combined therapy with lamivudine and ADV.